When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Science Behind a Good Night's Sleep
Raising Resilient Kids
Life Is Like a Game of Poker
Matters of the Heart
The Body That Got Me Through
That's What Friends Are For
The Change We Need
Introducing Chasing Life
It's Not Goodbye
Dr. Fauci's Long Year
Vaccines Behind Bars
India in Crisis
When Truth is Stranger Than Fiction
Tyler Perry’s Pandemic Response
What on Earth Happens Next?
An Immunologist Challenges the Status Quo
An American Success Story
I Got Vaccinated, But My Family Can’t
The Race Between Variants and Vaccines
Brazil's Covid Crisis
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First